Brooks Moore & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$1.55M |
| 2 |
Dow Inc
DOW
|
+$1.13M |
| 3 |
Qualcomm
QCOM
|
+$1.11M |
| 4 |
Alerian MLP ETF
AMLP
|
+$558K |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$554K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$891K |
| 2 |
Mondelez International
MDLZ
|
+$607K |
| 3 |
Abbott
ABT
|
+$492K |
| 4 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$479K |
| 5 |
Walt Disney
DIS
|
+$340K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.71% |
| 2 | Technology | 14.74% |
| 3 | Financials | 12.37% |
| 4 | Consumer Staples | 10.39% |
| 5 | Industrials | 8.24% |
Similar funds
Brooks Moore & Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Brooks Moore & Associates held 96 positions worth $116M, up 6.2% from $110M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brooks Moore & Associates deployed $5.15M of net new capital in Q2 2019, opening 6 new positions and adding to 35 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 5 shares worth $1.54M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $891K trimmed.
- Brooks Moore & Associates's largest Q2 2019 buy was Berkshire Hathaway Class A: 5 shares worth $1.54M.
- Brooks Moore & Associates added most to Alerian MLP ETF in Q2 2019, an estimated $558K increase.
- Brooks Moore & Associates's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $891K.
- Brooks Moore & Associates's ten largest holdings make up 29% of its $116M portfolio in Q2 2019.
- Brooks Moore & Associates opened 6 new positions and closed 0 in Q2 2019.
- Brooks Moore & Associates's portfolio value rose 6.2% quarter-over-quarter to $116M.
Based on Brooks Moore & Associates's 13F filing for Q2 2019, filed 9 Aug 2019.